Postdoctoral Research Associate in Centre for Stem Cells and Regenerative Medicine job with KINGS COLLEGE LONDON | 273388 – Times Higher Education…
stemadminStem Cell ResearchNo comments

Job descriptionThis is an exciting opportunity to join an interdisciplinary team of Kings College London scientists working on a funded MRC programme using human induced pluripotent stem cells as tools to understand the influence of natural genetic variation on HIV replication and identifying genes and networks that regulate HIV infection.The postdoc will work under the supervision of Dr. Alessandra Vigilante and Professor Michael Malim and play a key role in setting up an innovative inter-disciplinary strategy able to analyse different omics data sets and integrate them with phenotypic data. The project will employ state of the art genomics, statistical and bioinformatics approaches to discover novel human cell factors and pathways that regulate HIV-1 replication.We look for an ambitious candidate with established expertise in bioinformatics, specifically dealing with large omics data sets and data integration.

Read more
UCLA Broad Stem Cell Research Center receives $5 million …
stemadminStem Cell ResearchNo comments

The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA has been awarded $5 million by the California Institute for Regenerative Medicine, the states stem cell agency, to train young scientists and physicians to become leaders in the stem cell and regenerative medicine field. The five-year grant will enable the center to expand its Stem Cell Training Program, which was established in 2006 and funded by CIRM until 2015, when the agency changed its funding priorities. Since then, the program has been sustained by philanthropy

Read more
New nanochip reprograms cells in the body to perform different functions – New Atlas
stemadminStem Cell ResearchNo comments

A team of researchers led by Chandan Sen at the Indiana University School of Medicine, is moving a new nanochip device, which can reprogram skin cells in the body to become new blood vessels and nerve cells, out of the prototype phase. One of the more remarkable medical developments in the past two decades has been the ability to take specialized adult cells and revert them into the kind of non-specialized stem cells found in embryonic tissue.

Read more
BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn in ALS at the 4th Annual ALS ONE Research…
stemadminStem Cell ResearchNo comments

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the presentation of new analyses from the Phase 3 trial of NurOwn at the 4th Annual ALS ONE Research Symposium

Read more
‘Sleeping’ cancer cells explain why childhood leukaemia returns after years of treatment – The Institute of Cancer Research, London – The Institute of…
stemadminStem Cell ResearchNo comments

Image: deformed cells in the bone marrow, typical of leukaemia Leukaemic cancer cells can go to sleep and thus avoid the effects of chemotherapy, sometimes for years. It turns out that whether the cell is in this dormant state or not increases its chances of surviving chemotherapy and is completely independent from its mutations, as previously assumed. The discovery, made by a collaboration between researchers at The Institute of Cancer Research, London, and University College London (UCL),could help direct research towards new, more effective treatments for childhood leukaemia that stop cancer from coming back.

Read more

Theme: Illdy.